Test directory

This fully searchable directory currently lists all commercially available immunoassays and molecular tests for COVID-19 of which FIND is aware. Manufacturer performance data (sensitivity and specificity) are included, where known, alongside data from independent evaluations conducted by FIND, where applicable. We are continuing to build this database, and will be adding other tests (which for the moment are still listed here), as well as data from independent evaluations by other entities. This project is part of our work on the ACT-Accelerator Diagnostics Pillar. If you have any queries on the information included or updates to share on your test(s), please contact us

It has come to our attention that certain companies and websites are claiming to hold certificates endorsed by FIND and referring to the FIND name and logo. Third-party usage of the FIND logo to imply endorsement of services or diagnostic tools is not and has never been, authorized by FIND.

Last updated: 23 November 2021
RETURN TO MAIN SCREEN

2019-nCoV Neutralising Antibody Device

Prestige Diagnostics UK Ltd
Export this page in pdf
Regulatory status
CE-IVD
Time to result
0.17
Assay target
Antibody (serological)
Test format
Lateral flow assay (strip or cassette)
Technology principle
Antibody-based detection
Target analyte
IgG
Level of automation
Manual
Laboratory/Point-of-care
True Point of Care
Self-testing/Self-Collection
Intended for professional use only
Validated sample types
Plasma
serum
Connectivity
No
IMPACT OF SARS-COV-2 VARIANT:
Alpha - Unknown
Beta - Unknown
Gamma - Unknown
Manufacturer performance data
Sensitivity
96.6%
Specificity
98.5%